JNCCN 360

Editor:

Karl D. Lewis, MD

Advertisement

Advertisement

Steven M. Horwitz, MD, on PTCL and CTCL: Trial Results on Cerdulatinib, a Dual SYK/JAK Inhibitor

Karl D. Lewis, MD, on Selecting Patients for Treatment With Cemiplimab-rwlc

Theresa M. Medina, MD, on Basal Cell Carcinoma and Immunotherapy

Recent

Molecular Role of Cox-2 in Cutaneous Squamous Cell Carcinoma

Association Between Mercury Exposure and Non-Melanoma Skin Cancer

Nonsurgical Treatment for Invasive Cutaneous Squamous Cell Carcinoma: A Case Study

Researchers Identify New Genomic Areas Potentially Linked to Increased Skin Cancer Risk

Published

Medical Literature

Quantitative Proteomics Analysis Yields Insights in Merkel Cell Carcinoma

Potential Biomarker of Response to Vismodegib in Basal Cell Carcinoma

Update on Laser Therapies for Basal Cell Carcinoma

Researchers Identify New RNA Molecule in Growth of Squamous Cell Carcinoma

Ongoing

The Role Of PD-1 Inhibitors in The Evolving Landscape of Advanced Cutaneous Squamous Cell Carcinoma Treatment

A Multidisciplinary Approach to Individualized Patient Care: Non-Melanoma Skin Cancer

No Elevated Cancer Risk for RA Patients With Tocilizumab

Could AI Trained to ID Skin Cancer Attain Accuracy of Dermatologists?

Available

Clinical Trials

University of Michigan Comprehensive Cancer Center

The University of Alabama at Birmingham Comprehensive Cancer Center

University of Wisconsin Carbone Cancer Center

Moffitt Cancer Center

NCCN Resources

Copyright © 2020 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.